🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥🇬🇧 MEDICA 2022 is coming and SDS Optic will be there. You will find us in 𝗛𝗮𝗹𝗹 𝟭𝟮, 𝘀𝘁𝗮𝗻𝗱 𝟭𝟮𝗘𝟱𝟯-𝟰𝟯. Don't miss out our 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗮𝘁 𝘁𝗵𝗲 𝘀𝘁𝗮𝗴𝗲 (Hall 12, Stand 12E37), on Thursday (17'th of November) at 13:20!

It is the 3'rd fantastic day at MEDICA in Düsseldorf! 🩺🦿 There was a lot of great opportunities to meet new people and talk about a potential of the inPROBE technology. Good to be here. You will fin us in start-up area and Polish Medical Devices pavilion!

Merry Merry

🇬🇧 🔊 In the European Investment Bank data base official information has appeared about assessing of the potential financing in the venture debt loan up to EUR 10 mln. for SDS Optic company. 🤞

#GLOBOCAN data shows, that now we have over 2 mln new cases of #breastcancer globally, where almost 700k ends with deaths. Today is the #WorldCancerDay. Remember about regular breast cancer screenings. #BreastCancerAwareness #EarlyDetectionMatters #PinkRibon

🔥 We received a report confirming the completion of the safety phase of #ClinicalTrials of the #inPROBE, a #MedicalDevice designed to breast cancer real-time #diagnostics. 🔗inPROBE: inprobe.com 🔗SDS Optic: sdsoptic.pl/en/main-en/ #sdsoptic #innovation #medtech

Happy Easter everyone!🐣

🔔 Summary report for the first part of the #inPROBE clinical trials! ▪️ 21 patients in statistics ▪️ Conducted in 1 clinical center ▪️ No adverse events reported ▪️ Feedback to improve the procedure II part of the #ClinicalTrials is ahead of us! 🤞

🆕USPSTF recommendation "All women should get screened for breast cancer every other year starting at age 40 to reduce the risk of dying" ➡️After mammography (early stage), another important step: developing effective companion diagnostics, like #inPROBE uspreventiveservicestaskforce.org/uspstf/draft-r…

My DeviceTalks #Boston 2023 wrap up and keynotes! linkedin.com/pulse/device-t… SDS Optic inPROBE are on the right track and in line with the major market trends 💪💪

Real-time cancer diagnosis with a molecular test at the tip of a probe | SDS-OmiProbe Project | Results in brief | H2020 | CORDIS | European Commission ⁦EU Research Results⁩ ⁦European Innovation Council⁩ ⁦SDS Optic⁩ ⁦inPROBE⁩ ⁦European Commission⁩ ⁦ cordis.europa.eu/article/id/443…

🇬🇧 EU Research Results 🇪🇺 about SDS Optic and inPROBE 𝗔 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗱𝗲𝘃𝗶𝗰𝗲 𝗼𝗳𝗳𝗲𝗿𝘀 𝗳𝗮𝘀𝘁 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗼𝗳 𝗯𝗿𝗲𝗮𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗮 𝗻𝗲𝗲𝗱 𝗳𝗼𝗿 𝗯𝗶𝗼𝗽𝘀𝘆 More in the article 🔗 cordis.europa.eu/article/id/443…

Biotechnology Innovation Organization International Convention Day 2 Another day of tremendous talks, opportunities and ideas. We are more than happy to meet our friends from PAIH Central European BioForum BioInMed booth as well as the biosaxony , #Pennsylvania State and European Innovation Council #networking #bio2023

Very important update by ASCO & CAPathologists Clear need for novel and potentially disruptive innovations in the #HER2 #molecular #diagnostics #immunoassay space. SDS Optic EIT Health European Innovation Council NIH Society for Immunotherapy of Cancer SABCS ESMO - Eur. Oncology European Research Executive Agency FDA Oncology OncoAlert

Busy Friday in #Philadelphia reviewing different lab spaces with all SDS Optic #CoFounders #SDSOpticUSA moving ahead 💪 Great places, great people and great #Philly #Biotech #LifeSciences ecosystem inPROBE @PennsylvaniaGov City of Philadelphia

➡️We start technological cooperation with #Philips Engineering Solutions and the CSEM research and development institute from Switzerland. ➡️ Plan: to scale up, from the level of a clinical #prototype to the level of a #commercial / industrial device, the #inPROBE analyzer.

Great to be on the main page of the European Investment Bank Small thing but so important to everyone involved 👏 €10mln venture debt funding well secured !!! 💪 SDS Optic inPROBE European Commission European Innovation Council EISMEA Lublin

⭐️🇪🇺 EIB will support SDS Optic and #inPROBE platform technology with EUR 10 million! READ MORE: 🔗 sdsoptic.pl/en/eib-to-supp… CHECK OUT #EIB PRESS RELEASE 🔗 eib.org/en/press/all/2…

Exciting news! We've received positive results from the first part of the #inPROBE #ClinicalTrial, confirming the safety and achievement of the primary endpoint: initially determining the correlation between measurements using inPROBE® and traditional methods (#IHC/#FISH).

NEW BLOG POST #inPROBE® was designed to determine protein expression in a way different from the standard one. The determination is performed in vivo, directly in the patient's body, without needing to collect tissue. Read full article 👉 sdsoptic.pl/en/promising-p…